
Lytron SB 500mg/250mg Injection
Marketer
Lichem Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Lytron SB 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial for efficacy. Completing the entire course is vital, even with symptom improvement, as premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require urgent medical assistance. Prior to initiating treatment, inform your physician about all medications and health conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor might order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Lytron SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Lytron SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Lytron SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Lytron SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lytron SB 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Lytron SB 500mg/250mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this action by countering bacterial enzymes that would otherwise inactivate Ceftriaxone, thus maximizing its effectiveness.
SAFETY ADVICE
AlcoholSAFE
Lytron SB 500mg/250mg Injection may be consumed with alcohol without adverse effects.
PregnancySAFE IF PRESCRIBED
Lytron SB 500mg/250mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Lytron SB 500mg/250mg Injection necessitates prudence during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Lytron SB 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Operation of vehicles is contraindicated while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lytron SB 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 500mg/250mg Lytron SB injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for the 500mg/250mg Lytron SB injection isn't suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Lytron SB 500mg/250mg Injection :
Omitting a scheduled dose of Lytron SB 500mg/250mg Injection warrants immediate medical advice.
Facts to Know About Lytron SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
